Gilmore SA - Search Results

1

Microbiological evaluation of foodservice contact surfaces in Iowa assisted-living facilities.

Sneed J, Strohbehn C, Gilmore SA, Mendonca A. Sneed J, et al. Among authors: gilmore sa. J Am Diet Assoc. 2004 Nov;104(11):1722-4. doi: 10.1016/j.jada.2004.08.026. J Am Diet Assoc. 2004. PMID: 15499361

2

Food safety practices and readiness to implement HACCP programs in assisted-living facilities in Iowa.

Sneed J, Strohbehn C, Gilmore SA. Sneed J, et al. Among authors: gilmore sa. J Am Diet Assoc. 2004 Nov;104(11):1678-83. doi: 10.1016/j.jada.2004.08.031. J Am Diet Assoc. 2004. PMID: 15499354

3

Food safety practices and HACCP implementation: perceptions of registered dietitians and dietary managers.

Strohbehn CH, Gilmore SA, Sneed J. Strohbehn CH, et al. Among authors: gilmore sa. J Am Diet Assoc. 2004 Nov;104(11):1692-9. doi: 10.1016/j.jada.2004.08.029. J Am Diet Assoc. 2004. PMID: 15499356

4

Standards of Practice criteria: consultant dietitians in health care facilities.

Gilmore SA, Niedert KC, Leif E, Nichols P. Gilmore SA, et al. J Am Diet Assoc. 1993 Mar;93(3):305-8. doi: 10.1016/0002-8223(93)91556-6. J Am Diet Assoc. 1993. PMID: 8440829

5

Clinical indicators associated with unintentional weight loss and pressure ulcers in elderly residents of nursing facilities.

Gilmore SA, Robinson G, Posthauer ME, Raymond J. Gilmore SA, et al. J Am Diet Assoc. 1995 Sep;95(9):984-92. doi: 10.1016/S0002-8223(95)00271-5. J Am Diet Assoc. 1995. PMID: 7657913

6

Clinical dietetics changes due to cost-reduction activities in healthcare systems.

Kwon J, Gilmore SA, Oakland MJ, Shelley MC 2nd. Kwon J, et al. Among authors: gilmore sa. J Am Diet Assoc. 2001 Nov;101(11):1347-50. doi: 10.1016/s0002-8223(01)00322-4. J Am Diet Assoc. 2001. PMID: 11716316

7

Phenotypic and functional characterization of posoleucel, a multivirus-specific T cell therapy for the treatment and prevention of viral infections in immunocompromised patients.

Vasileiou S, Kuvalekar M, Velazquez Y, Watanabe A, Leen AM, Gilmore SA. Vasileiou S, et al. Among authors: gilmore sa. Cytotherapy. 2024 Mar 19:S1465-3249(24)00100-2. doi: 10.1016/j.jcyt.2024.03.012. Online ahead of print. Cytotherapy. 2024. PMID: 38597860

8

Final Outcomes from a Phase 2 Trial of Posoleucel in Allogeneic Hematopoietic Cell Transplant Recipients.

Dadwal SS, Bansal R, Schuster M, Yared JA, Myers GD, Matzko ME, Adnan S, McNeel D, Ma J, Gilmore SA, Vasileiou S, Leen AM, Hill JA, Young JA. Dadwal SS, et al. Among authors: gilmore sa. Blood Adv. 2024 Apr 9:bloodadvances.2023011562. doi: 10.1182/bloodadvances.2023011562. Online ahead of print. Blood Adv. 2024. PMID: 38593233

9

Characterization of a KDM5 small molecule inhibitor with antiviral activity against hepatitis B virus.

Gilmore SA, Tam D, Cheung TL, Snyder C, Farand J, Dick R, Matles M, Feng JY, Ramirez R, Li L, Yu H, Xu Y, Barnes D, Czerwieniec G, Brendza KM, Appleby TC, Birkus G, Willkom M, Kobayashi T, Paoli E, Labelle M, Boesen T, Tay CH, Delaney WE 4th, Notte GT, Schmitz U, Feierbach B. Gilmore SA, et al. PLoS One. 2022 Dec 7;17(12):e0271145. doi: 10.1371/journal.pone.0271145. eCollection 2022. PLoS One. 2022. PMID: 36477212 Free PMC article.

10

Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability.

Fumagalli V, Venzin V, Di Lucia P, Moalli F, Ficht X, Ambrosi G, Giustini L, Andreata F, Grillo M, Magini D, Ravà M, Friedrich C, Fontenot JD, Bousso P, Gilmore SA, Khan S, Baca M, Vivier E, Gasteiger G, Kuka M, Guidotti LG, Iannacone M. Fumagalli V, et al. Among authors: gilmore sa. Sci Immunol. 2022 Feb 25;7(68):eabi6112. doi: 10.1126/sciimmunol.abi6112. Epub 2022 Feb 25. Sci Immunol. 2022. PMID: 35213210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page